Insmed Inc banner

Insmed Inc
NASDAQ:INSM

Watchlist Manager
Insmed Inc Logo
Insmed Inc
NASDAQ:INSM
Watchlist
Price: 115.62 USD -2.01% Market Closed
Market Cap: $25B

Wall St Price Targets

INSM Price Targets Summary
Insmed Inc

Wall Street analysts forecast INSM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INSM is 209.02 USD with a low forecast of 141.4 USD and a high forecast of 255.15 USD.

Lowest Forecast
Price Target
141.4 USD
22% Upside
Average Forecast
Price Target
209.02 USD
81% Upside
Highest Forecast
Price Target
255.15 USD
121% Upside
Insmed Inc Competitors:
Price Targets
TARA
Protara Therapeutics Inc
391% Upside
EBMT
Eagle Bancorp Montana Inc
3% Upside
TTD
Trade Desk Inc
38% Upside

Revenue
Forecast

N/A
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Revenue over the next 8 years is 44%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is INSM's stock price target?
Price Target
209.02 USD

According to Wall Street analysts, the average 1-year price target for INSM is 209.02 USD with a low forecast of 141.4 USD and a high forecast of 255.15 USD.

What is the Revenue forecast for Insmed Inc?
Projected CAGR
44%

The compound annual growth rate for Revenue over the next 8 years is 44%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett